Close

CellRapeutics™ TOPO TA Cloning Kit (CART-016CL)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Specific Inquiry

  • Size:
  Add to Cart
  • Product Name
  • CellRapeutics™ TOPO TA Cloning Kit
  • Cat. No.
  • CART-016CL
  • General Description
  • TOPO TA Cloning Kits for Subcloning provide a highly efficient, 5-minute, one-step cloning strategy ("TOPO cloning") for the direct insertion of Taq polymerase–amplified PCR products into a plasmid vector for subcloning. Each kit uses the pCR™ 2.1-TOPO TA vector with convenient restriction sites for subcloning. The cloning kits are available with a variety of competent cells, or without competent cells, depending upon your needs and budget. • Fast and easy—go from PCR to clones in just 3 steps and in as little as 5 minutes hands-on time
    • Efficient—obtain up to 95% clones with correct insert
    • Proven—reliable performance for over a decade with over 4,000 citations
    • Simple—no ligase, post-PCR procedures, or PCR primers containing specific sequences are required TOPO TA Cloning Kits for Subcloning—overview

    • Vector: pCR™ 2.1-TOPO TA vector—subcloning vector with 15 convenient restriction sites flanking your insert for easy, directional subcloning
    • Cloning method: TOPO TA Cloning —Topoisomerase I–based, 5-minute ligation of PCR products with 3′-A overhangs (Taq polymerase amplified) to TOPO vector with T overhangs
    • Competent cells: various options—choose from kits with either general, high-efficiency, bacteriophage T1–resistant, fast-growing competent cells, or use your own

    pCR™ 2.1-TOPO TA vector—cloning and subcloning simplicity
    The pCR™ 2.1-TOPO TA vector is linearized with 3'-thymidine (T) overhangs for direct ligation of Taq polymerase–amplified PCR products (TA cloning) and is "activated" with covalently bound Topoisomerase I. There is no need to add ligase and cloning is complete in 5 minutes. EcoRI sites flanking the PCR product insertion site allow for easy excision of inserts or use any combination of 15 convenient restriction sites flanking your PCR insert for easy, directional subcloning.

    pCR™ 2.1-TOPO TA clone selection and manipulation
    The pCR™ 2.1-TOPO TA vector contains both ampicillin and kanamycin resistance markers and the LacZα gene for blue/white screening.

    Simplified TOPO -based cloning
    Using TOPO cloning technology, there is no need for PCR primers containing specific sequences, post-PCR procedures, vector preparation, or other time-intensive DNA manipulation steps. Just add your PCR reaction straight to the provided topoisomerase-charged vector, incubate 5 minutes, and transform E. coli competent cells.
    Efficient cloning
    With up to 95% of clones carrying the desired insert, you can screen less clones, saving time and money. The pCR 2.1-TOPO TA vector used in this kit comes with 3'-T overhangs for efficient ligation of Taq polymerase–amplified PCR products, which contain 3'-A overhangs.

    The standard in cloning
    When it comes to cloning, TOPO cloning technology has been a reliable partner for thousands of scientists for over ten years. Fast, simple-to-use, and efficient, TOPO cloning has been applied to many different vectors for a wide array of applications.

    TOPO TA Cloning Kits for Subcloning—kit options
    The TOPO TA Cloning Kit for Sequencing can be purchased with a variety of competent cells that deliver different advantages depending upon your needs:

    • General cloning: TOP10 cells
    • High-efficiency cloning: TOP10 Electrocomp Cells
    • General cloning, bacteriophage T1 resistance: DH5α-T1R cells
    • Fast growth: Mach1™ -T1R Chemically Competent E. Coli
    • Provide your own: for flexibility and to save money
  • Components
  • Box 1:
    • Topoisomerase I-activated pCR™2.1-TOPO vector
    • PCR buffer
    • Salt solution
    • dNTPs
    • Control template
    • M13 forward and reverse primers
    • Control PCR primers
    • Sterile water
  • Number of Reactions
  • 20 Reactions
  • Vector Type
  • TOPO-TA Cloning Vectors, pCR
  • Cloning Method
  • TOPO-TA
  • Bacterial or Yeast Strain
  • Not Included
  • Antibiotic Resistance (Bacterial)
  • Ampicillin (AmpR), Kanamycin (KanR)
  • PCR Enzyme
  • Taq Polymerase
  • Directionality
  • No
  • Replication Origin
  • pUC Origin, f1 Origin
  • Product Size
  • 25 reactions
  • Shipping Condition
  • Dry Ice
  • Storage Conditions
  • Store at -5 to -30°C.
    All reagents are stable for 6 months when properly stored.

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ TOPO TA Cloning Kit (CART-016CL). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.